LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

Inicio・Lista de Acciones・AbCellera Biologics Inc

AbCellera Biologics Inc

Abierto

SectorSalud

3.55 2.01

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.48

Máximo

3.66

Métricas clave
By Trading Economics
Ingresos	48M -8.9M
Ventas	36M 45M
Margen de beneficio	-19.942
Empleados	562
EBITDA	22M -18M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+102.9% upside

Dividendos
By Dow Jones
Próximas Ganancias	7 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	236M 1.1B
Apertura anterior	1.54
Cierre anterior	3.55

Noticias sobre sentimiento de mercado

By Acuity

76%

24%

322 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

1.99 / 2.635 Soporte y Resistencia

AbCellera Biologics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 mar 2026, 18:13 UTC

Adquisiciones, fusiones, absorciones

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9 mar 2026, 17:20 UTC

Noticias de Eventos Importantes

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9 mar 2026, 17:15 UTC

Adquisiciones, fusiones, absorciones

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10 mar 2026, 00:00 UTC

Noticias de Eventos Importantes

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9 mar 2026, 23:52 UTC

Charlas de Mercado

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9 mar 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9 mar 2026, 23:50 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 mar 2026, 23:46 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Correction to Crude Prices Market Talk on March 9

9 mar 2026, 23:42 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9 mar 2026, 23:08 UTC

Noticias de Eventos Importantes

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9 mar 2026, 23:07 UTC

Noticias de Eventos Importantes

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9 mar 2026, 21:29 UTC

Adquisiciones, fusiones, absorciones

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9 mar 2026, 21:28 UTC

Adquisiciones, fusiones, absorciones

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9 mar 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 mar 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 mar 2026, 20:47 UTC

Noticias de Eventos Importantes

The 24 Hours When Oil Markets Went Wild -- WSJ

9 mar 2026, 20:33 UTC

Noticias de Eventos Importantes

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9 mar 2026, 20:14 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9 mar 2026, 19:33 UTC

Noticias de Eventos Importantes

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9 mar 2026, 19:17 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9 mar 2026, 19:14 UTC

Charlas de Mercado

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9 mar 2026, 19:00 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

9 mar 2026, 18:23 UTC

Charlas de Mercado

Noticias de Eventos Importantes

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9 mar 2026, 17:58 UTC

Adquisiciones, fusiones, absorciones

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9 mar 2026, 17:57 UTC

Adquisiciones, fusiones, absorciones

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9 mar 2026, 17:41 UTC

Noticias de Eventos Importantes

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9 mar 2026, 17:41 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9 mar 2026, 17:08 UTC

Charlas de Mercado

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9 mar 2026, 17:04 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

9 mar 2026, 17:04 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Comparación entre iguales

Cambio de precio

AbCellera Biologics Inc Esperado

Precio Objetivo

By TipRanks

102.9% repunte

Estimación a 12 meses

Media 7 USD 102.9%

Máximo 7 USD

Mínimo 7 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AbCellera Biologics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para AbCellera Biologics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.99 / 2.635Soporte y Resistencia

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

Sentimiento

By Acuity

322 / 351 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de AbCellera Biologics Inc

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.